Document Detail
Use of fluvastatin following percutaneous coronary intervention
Abstract/OtherAbstract :
The use of percutaneous coronary intervention to remove occlusions from coronary arteries has increased substantially over recent years. Concurrent with the use of percutaneous coronary intervention, the use of lipid-lowering medications, such as statins, has increased. The Lescol Intervention and Prevention Study showed significant reductions with statins in postpercutaneous coronary intervention cardiac events. The cost- effectiveness of initiating statin use for all percutaneous coronary intervention patients is favorable, with significant health benefits (including improved survival) for relatively low additional costs (e.g., £3207 per quality-adjusted life year in the UK). Fluvastatin is the lowest cost statin currently available (less than the price of generic statins). Key economic issues include estimates of the current use of statins at the time of percutaneous coronary intervention and the likelihood of switching from more expensive statins to fluvastatin., Yes, Yes
Authors :
Scuffham, Paul Anthony
Related Documents :
36625116 - Use of fluvastatin following percutaneous coronary intervention
7721276 - Pyruvate thiolester for the prevention of reperfusion injury
33778726 - Complementary utility of multislice computed tomographic coronary angiography for detec...
Contributors :
Publication Detail :
Publisher :, Future Drugs Ltd, United Kingdom,     Type :  c1x, Journal Articles (Refereed Article), Full-text link or file     Format :  -    
Date Detail :
2006-07-07, 2009-03-02, 2009-03-02, 2005
Subject :
Griffith Health Faculty, 321202, 321299, 340204, PRE2009-Epidemiology, PRE2009-Health Economics, PRE2009-Public Health and Health Services
Coverage :
Relation :
2, Expert Review of Pharmacoeconomics & Outcomes Research, 113, 123, N, 5
Source :
Copyright Information :
Other Details :
Languages :  en_AU    
Export Citation :
APA/MLA Format     Download EndNote     Download BibTex

Previous Document:  What's needed to increase research capacity in rural primary health care?
Next Document:  Le diagnostic des carences en Iode et Sélénium chez les bovins